Histogen Inc. short interest in 2021
In 2021, Histogen Inc.'s disclosed short interest ran from 0.76% of shares outstanding on 15 Jan 2021 to 0.44% on 15 Dec 2021, a change of -0.32 percentage points. The year's high was 3.58% on 15 Mar 2021 and its low 0.42% on 30 Sep 2021, averaging 1.23% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.63 days on 14 May 2021. Full history: Histogen Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2021 in figures
- Start of year
- 0.76% (15 Jan 2021)
- End of year
- 0.44% (15 Dec 2021)
- Change
- -0.32 pp
- High
- 3.58% (15 Mar 2021)
- Low
- 0.42% (30 Sep 2021)
- Average
- 1.23%
- Highest days to cover
- 1.63 (14 May 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 0.76% | 1.00 | |
| 15 Mar 2021 | 3.58% | 1.00 | 10-K filed, results (8-K) |
| 31 Mar 2021 | 2.56% | 1.00 | |
| 15 Apr 2021 | 2.25% | 1.49 | |
| 30 Apr 2021 | 2.22% | 1.00 | |
| 14 May 2021 | 1.78% | 1.63 | 10-Q filed, results (8-K) |
| 28 May 2021 | 1.27% | 1.58 | |
| 15 Jun 2021 | 1.06% | 1.00 | |
| 30 Jun 2021 | 1.44% | 1.00 | |
| 15 Jul 2021 | 1.10% | 1.00 | |
| 30 Jul 2021 | 0.48% | 1.00 | |
| 13 Aug 2021 | 1.01% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 0.70% | 1.00 | |
| 15 Sep 2021 | 0.64% | 1.00 | |
| 30 Sep 2021 | 0.42% | 1.00 | |
| 15 Oct 2021 | 0.57% | 1.00 | |
| 29 Oct 2021 | 0.67% | 1.00 | |
| 15 Nov 2021 | 0.91% | 1.00 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 0.68% | 1.00 | |
| 15 Dec 2021 | 0.44% | 1.00 |
See also: Histogen Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.